AzTrials
AzTrials

Low Back PainPhase 4SODANCT00443781

Study Of Disc Anaesthesia For The Preoperative Diagnosis Of Chronic Lower Back Pain

A Phase 4 study testing functional anesthetic discography and provocative discography in people with Low Back Pain, run by Medtronic Spine LLC at 10 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The primary objective of this study is to document and compare diagnostic test results and procedure safety in subjects undergoing both Functional Anaesthetic DiscographyTM (F.A.D.) and provocative discography (PD) and determine the appropriateness of the F.A.D. Read more about this study

Who is it for?
Ages 21 years and older
Conditions the study is for
Low Back Pain
What is being tested?
functional anesthetic discography and provocative discography
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
62 participants
Where
10 sitesUnited States
Study dates
Mar 2007to Jun 2009
Phase
Phase 4
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age > 21.
  • Chronic axial low back pain without radicular pain for > six months, not responding to at least three months of non-surgical management under the direction of a physician.
  • One or two discs at L5/S1, L4/L5 or L3/L4 with abnormal findings by MRI, including any of the following: loss of disc hydration, loss of disc height, high intensity zone (HIZ), Modic changes at adjacent vertebral endplates, or herniation without nerve root compression.
  • Subject states that he/she is willing to undergo lumbar spinal fusion, disc replacement, or other definitive treatment if eventual diagnosis supports such treatment.
  • Physician believes that discography is clinically indicated for the purpose of surgical decision-making for the subject.
  • Pre-treatment low back pain by numerical rating scale (NRS) score > 4 (measured as average in last 24 hours on a 0-10 scale).
Show all 9Show fewer
  • Pre-treatment Oswestry Disability Index (ODI) > 40 (0 - 100 scale).
  • Subject states availability for all study visits.
  • Subject is able to understand the risks and benefits of participating in the study and provides written informed consent.

Who cannot join

  • Known osteoporosis or osteopenia, metabolic bone disorder, or history of chronic steroid use (the equivalent of 7.5 milligrams of daily prednisone use for > 6 months).
  • Suspected painful disc degeneration (based on clinical examination and MRI findings) outside of L5/S1, L4/L5 or L3/L4 levels.
  • MRI shows disc abnormalities (listed in Inclusion Criteria #3) at all 3 lower lumbar discs (L3/L4, L4/L5 and L5/S1).
  • Abnormal neurologic exam attributable to lumbar disc disease, herniation, or lumbar stenosis.
  • Back, buttock or pelvic pain suspected to be due to spinal stenosis, spinal fractures, infection, cancer, facet arthropathy or other hip or pelvis pathology.
  • Schmorl's node or endplate disruption evident on MRI at L5/S1, L4/L5, or L3/L4.
Show all 14Show fewer
  • Medical history, physical examination or radiographic evidence (e.g., disc height too narrow) to suggest that either PD or F.A.D. may not be technically feasible.
  • Any previous lumbar spine fusion or disc replacement.
  • More than grade 1 spondylolisthesis as assessed by x-ray or MRI.
  • Significant clinical comorbidity that may potentially interfere with data collection or follow-up (e.g., dementia, severe comorbid illness).
  • History of major depression, psychosis or somatization disorder, or panic disorder.
  • Allergy to any materials used in PD or F.A.D. devices, contrast, lidocaine, or bupivacaine.
  • Any evidence of disc or systemic infection.
  • Pregnant or child-bearing potential and not currently on adequate birth control method.

Trial locations and contacts

10 sites in 1 country.

10 sites in 1 country

United States10 sites
  • Emory Orthopaedics & Spine Center

    Atlanta, Georgia, 30329

  • Spine Source

    Beverly Hills, California, 90212

  • Pacific Spine Clinic

    Escondido, California, 92025

  • Hanover Orthopaedic Associates, Inc.

    Hanover, Pennsylvania, 17331

  • The Spine and Neurosurgery Center

    Huntsville, Alabama, 35801

  • Evergreen Surgical Center

    Kirkland, Washington, 98034

  • Milwaukee Neurological Institute

    Milwaukee, Wisconsin, 53233

  • Texas Back Institute

    Plano, Texas, 75093

  • UCSD Orthopaedic Surgery

    San Diego, California, 92103

  • East Texas Medical Center

    Tyler, Texas, 75701

Other trials in United States

About this study

The primary objective of this study is to document and compare diagnostic test results and procedure safety in subjects undergoing both Functional Anaesthetic DiscographyTM (F.A.D.) and provocative discography (PD) and determine the appropriateness of the F.A.D. procedure data collection script for use in a larger clinical trial.

Conditions
Low Back Pain
Being tested
functional anesthetic discography, provocative discography
Keywords
low back pain, degenerative disc disease
Medical subject headings
Low Back Pain, Intervertebral Disc Degeneration

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • functional anesthetic discographyProcedure or surgery

    Functional Anesthetic Discography (F.A.D.) involves the placement and anchoring of a small catheter into a disc. After placement, functional testing is performed, in which the subject elicits his/her back pain via functional maneuvers or postures. Local anaesthetic is then delivered into the target disc through the catheter and the effect on functional back pain is noted.

  • provocative discographyProcedure or surgery

    Provocative discography (PD) has been used as a preoperative diagnostic tool for patients with back pain attributed to degenerative disc disease considering lumbar disc surgery. During PD, a clinically suspected disc is accessed with a needle and injected under pressure with radiopaque contrast dye. The subject rates his/her experience of pain for intensity and whether the pain is exactly the same as ("concordant") or different from ("not concordant" or "discordant") typical back pain.

Study groups in NCT00443781
Study groupRoleWhat they receive
PD and F.A.D. diagnostic testingOtherNot described
Receives: Procedure: functional anesthetic discography; Procedure: provocative discography

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Difference in Number of Magnetic Resonance Imaging (MRI)-Positive Discs Diagnosed Positive by Provocative Discography (PD) and Functional Anesthetic Discography (F.A.D.)

    For provocative discography (PD), a positive response at an individual disc requires all of the following findings: pain intensity (>=7/10 on 0-10 Numerical Rating Scale, NRS) as rated by subjects on injecting contrast into a disc; concordancy (pain reproduces typical back pain exactly). For Functional Anesthetic Discography (F.A.D.), a positive test at an individual disc level is defined as improvement in self-rated pain of >=2 Numerical Rating Scale (NRS) points AND >33% on 0-10 Numerical Rating Scale 10 minutes after injection of lidocaine.

    Measured: Approximately 2 hours per subject

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Mar 2007 (estimated)
  2. Study startMar 2007
  3. Primary completionJun 2009
  4. Study completionJun 2009

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
62 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00443781
Sponsor's protocol ID
SP0603
Acronym
SODA
Status last verified
Mar 2012
First submitted
2 Mar 2007
Last updated
5 Jan 2021
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing functional anesthetic discography and provocative discography in people with Low Back Pain, run by Medtronic Spine LLC at 10 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Jan 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 10 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Yes. Results are posted in the registry (first posted 23 Aug 2010). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Difference in Number of Magnetic Resonance Imaging (MRI)-Positive Discs Diagnosed Positive by Provocative Discography (PD) and Functional Anesthetic Discography (F.A.D.) (time frame: Approximately 2 hours per subject). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jan 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in